Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The term "game-changing" is overused for too many up-and-coming companies, but in this case, the description fits.

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The Nasdaq Biotechnology Index has increased 2.62% in the past five trading sessions and MRNA’s shares ...

Biotech stocks may be primed for a long-term bull run. Learn why IBB, XBI, and macro trends like rate cuts make biotech an attractive sector now.

Officers, directors, and beneficial owners have shelled out more than $10 million on each of the following four biotech stocks. Officers, 10% owners, and other insiders have shelled out more than ...

Such companies are relatively rare. There is one such stock to consider buying into sooner rather than later, though. That's a biotech company called Recursion Pharmaceuticals (NASDAQ: RXRX).